-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FoPE8jcr/lwJcDS6Gg4Z38YK/poXjix0bI5RRKLQnspS7m5w9PZtXuUaA+cb5lDo 8QMMAHKGx7PqcdXvACFUag== /in/edgar/work/20000822/0000950157-00-000438/0000950157-00-000438.txt : 20000922 0000950157-00-000438.hdr.sgml : 20000922 ACCESSION NUMBER: 0000950157-00-000438 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000822 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: HEXCEL CORP /DE/ CENTRAL INDEX KEY: 0000717605 STANDARD INDUSTRIAL CLASSIFICATION: [3460 ] IRS NUMBER: 941109521 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: SEC FILE NUMBER: 005-14306 FILM NUMBER: 707503 BUSINESS ADDRESS: STREET 1: 281 TRESSER BOULEVARD STREET 2: TWO STAMFORD PLZ CITY: STAMFORD STATE: CT ZIP: 06901 BUSINESS PHONE: 2039690666 MAIL ADDRESS: STREET 1: 281 TRESSER BLVD. STREET 2: TWO STAMFORD PLAZA, 16TH FLOOR CITY: STAMFORD STATE: CT ZIP: 06901-8781 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CIBA SPECIALTY CHEMICALS HOLDING INC /FI/ CENTRAL INDEX KEY: 0001035497 STANDARD INDUSTRIAL CLASSIFICATION: [ ] FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: KLYBECKSTRASSE 141 CITY: CH 4002 BASEL BUSINESS PHONE: 41616963415 MAIL ADDRESS: STREET 1: KLYBECKSTRASSE 141 CITY: CH 4002 BASEL FORMER COMPANY: FORMER CONFORMED NAME: CIBA SPECIALTY CHEMICALS HOLDING INC /FI/ DATE OF NAME CHANGE: 19970408 SC 13D/A 1 0001.txt SCHEDULE 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 3)* Hexcel Corporation ------------------------- (Name of Issuer) Common Stock, Par Value $0.01 Per Share ------------------------- (Title of Class of Securities) 428290 10 0 ---------- (CUSIP Number) Oliver Strub, Esq. John J. McGraw, Esq. Ciba Specialty Chemicals Ciba Specialty Chemicals Holding Inc. Corporation Ciba Specialty Chemicals Inc. P.O. Box 2005 Klybeckstrasse 141 560 White Plains Road CH - 4002, Basel Tarrytown, New York 10591 Switzerland (914) 785-2000 41-61-696-3415 ----------------------------------------------------- (Name, Address and Telephone Number of Persons Authorized to Receive Notices and Communications) With a copy to: Philip A. Gelston, Esq. Cravath, Swaine & Moore Worldwide Plaza 825 Eighth Avenue New York, New York 10019 ------------------------- August 21, 2000 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box: [ ] * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). 2 This Amendment No. 3 amends and supplements the Statement on Schedule 13D filed with the Securities and Exchange Commission on October 4, 1995, as amended by Amendment No. 1 thereto filed on March 6, 1996 and Amendment No. 2 thereto filed on March 11, 1997 (collectively, the "Statement"). Capitalized terms used and not defined herein shall have the meanings assigned to such terms in the Statement. Item 4. Purpose of Transaction. Item 4 is hereby amended by adding the following language at the end of this item: Ciba has determined that its investment in the Issuer has become a non-strategic asset. Accordingly, Ciba has advised the Issuer that it would be interested in disposing of all or a substantial portion of its investment in the Issuer if an acceptable price could be obtained, and Ciba has begun to investigate what alternatives consistent with its obligations under the Governance Agreement may be available at this time. Pending any sale of its entire interest, Ciba intends to continue to exercise its rights under the Governance Agreement. 3 SIGNATURE After reasonable inquiry and to the best of the knowledge and belief of the undersigned, the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated August 21, 2000 CIBA SPECIALTY CHEMICALS HOLDING INC., by by /s/ Hans - Ulrich Muller /s/ Oliver Strub - ------------------------------------- ------------------------- Name: Hans - Ulrich Muller Name: Oliver Strub Title: Secretary to the Board Title: Corporate Counsel After reasonable inquiry and to the best of the knowledge and belief of the undersigned, the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated August 21, 2000 CIBA SPECIALTY CHEMICALS INC., by by /s/ Hans - Ulrich Muller /s/ Oliver Strub - -------------------------------------------- -------------------------- Name: Hans - Ulrich Muller Name: Oliver Strub Title: General Counsel Title: Corporate Counsel After reasonable inquiry and to the best of the knowledge and belief of the undersigned, the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated August 21, 2000 CIBA SPECIALTY CHEMICALS CORPORATION, by /s/ John J. McGraw ----------------------------------------- Name: John J. McGraw Title: Vice President, General Counsel and Secretary -----END PRIVACY-ENHANCED MESSAGE-----